|
Scenario
|
Time to diagnosis (mean)
|
Time to linkage to care (mean)
|
Loss to follow-up rate (%/y)
|
Treatment eligibility
|
Treatment rate among eligible PWID
|
%SVR
|
|---|
|
1 (reference)
|
2 y
|
1.7 y
|
10.2%/y
|
F0 → F4
|
5%/y
|
81%
|
|
2
|
0.5 y
|
1.7 y
|
10.2%/y
|
F0 → F4
|
5%/y
|
81%
|
|
3
|
2 y
|
0.5y
|
5%/y
|
F0 → F4
|
5%/y
|
81%
|
|
4
|
2 y
|
1.7 y
|
10.2%/y
|
F0 → F4
|
5%/y
|
90%
|
|
5
|
2 y
|
1.7 y
|
10.2%/y
|
F0 → F4
|
10%/y
|
81%
|
|
6
|
2 y
|
1.7 y
|
10.2%/y
|
F0 → F4
|
20%/y
|
81%
|
|
7
|
0.5 y
|
0.5 y
|
5%/y
|
F0 → F4
|
20%/y
|
90%
|
|
8
|
0.5 y
|
0.5 y
|
5%/y
|
F2 → F4
|
100%/y
|
90%
|
-
PWID People who inject drugs, SVR sustained virological response
